Delivery Order SPE2DB22D2206-SPE2DB24FEC38
Award Date 11/13/23
Potential Completion Date 12/5/23
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $8,312.74 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply RITUXAN HYCELA 1,600 MG-26,800 13.4ML pharmaceutical products. The order was awarded on October 30, 2023 under the company's indefinite delivery contract with no set-aside designation specified. Performance will occur at Amerisourcebergen's headquarters location in Conshohocken, Pennsylvania...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $16,625.48 to supply RITUXAN HYCELA 1,600 MG-26,800 13.4ML pharmaceutical products. As the prime contractor, Amerisourcebergen will deliver the specified medications to support DLA medical facilities by December 5, 2023 from its headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award made against an existing...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency Troop Support Medical Center. This $12,469.11 order is to supply 1,600 mg-26,800 13.4ml doses of RITUXAN HYCELA for medical treatment programs and facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 29,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical to supply $4,156.37 worth of RITUXAN HYCELA 1,600 MG-26,800 13.4ML pharmaceutical products. The delivery order has a completion date of November 24, 2023 and was awarded on November 1, 2023 without a set aside designation. Performance will occur at Amerisourcebergen's...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Valued at $16,158.79, this order is for the supply of 1,600 mg-26,800 mg/13.4ml doses of RITUXAN HYCELA to the place of performance in Conshohocken, Pennsylvania by the completion date of December 4, 2023. No set-aside designation was used for this award. As a prime contractor supporting DLA...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $7,409.20 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 1,400 mg-23,400 11.7ml doses of RITUXAN HYCELA. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by November 17, 2023. No set-aside designation was applied to this order, which was issued against an indefinite-delivery...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Valued at $4,156.37, this order is for the supply of 1,600 mg-26,800 mg RITUXAN HYCELA in a 13.4ml formulation to the place of performance in Conshohocken, Pennsylvania by November 22, 2023. No set aside designation was applied to this award issued by DLA Troop Support Medical in support of...
- The Defense Logistics Agency awarded a $14,818 delivery order to Amerisourcebergen Drug Corporation for RITUXAN HYCELA, a monoclonal antibody used to treat certain types of cancer and autoimmune disorders. The firm fixed price order is for delivery of 1,400 mg doses to a facility in Conshohocken, Pennsylvania between June and July 2023. Amerisourcebergen will fulfill the order as the prime contractor from its Corporate Office Division. No additional details were provided regarding subcontractors...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $14,818.40 to Amerisourcebergen Drug Corporation for 1,400 mg-23,400 11.7ml doses of rituximab and hyaluronidase human injection. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a period spanning September 26, 2023 through October 18, 2023. The delivery order was issued against an unidentified indefinite-delivery/indefinite-quantity contract...
- The Defense Logistics Agency awarded a delivery order valued at $37,180.20 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 11.7 mL on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award under a larger vehicle, reflecting AmerisourceBergen's established...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEC38Delivery Order
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $14,818.40 to supply RITUXAN HYCELA 1,400 MG-23,400 11.7ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 5, 2023. No set-aside designation was applied to this award made against an existing indefinite-delivery contract to provide pharmaceuticals and medical supplies in support of DLA and Department of Defense medical treatment programs.
Generated 2/12/24, 9:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||